Prospective acid reflux study of Iran (PARSI): Methodology and study design

BMC Gastroenterology

Volumn 7, Issue , 2007, Pages

  Nasseri Moghaddam, Siavosh ^a   Razjouyan, Hadi ^a   Alimohamadi, Seyed Maysam ^a   Mamarabadi, Mansoureh ^a   Ghotbi, Mohamad Hamed ^a   Mostajabi, Pardis ^a   Sohrabpour, Amir Ali ^a   Sotoudeh, Masoud ^a   Abedi, Behnoush ^a   Mofid, Azadeh ^a   Nouraie, Mehdi ^a   Tofangchiha, Shahnaz ^a   Malekzadeh, Reza ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

FAMOTIDINE; NORTRIPTYLINE; OMEPRAZOLE; PROTON PUMP INHIBITOR; RANITIDINE;

ADOLESCENT; ADULT; ARTICLE; BEDTIME DOSAGE; BLOOD SAMPLING; CLINICAL PROTOCOL; COHORT ANALYSIS; DATA ANALYSIS; DATA BASE; DISEASE COURSE; DRUG WITHDRAWAL; FOLLOW UP; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL BIOPSY; GASTROINTESTINAL ENDOSCOPY; HUMAN; INTERVIEW; IRAN; MEDICAL SPECIALIST; METHODOLOGY; MOLECULAR EPIDEMIOLOGY; OUTCOME ASSESSMENT; OUTPATIENT DEPARTMENT; PATIENT REFERRAL; PROSPECTIVE STUDY; RELIABILITY; SYMPTOM; TREATMENT RESPONSE; BIOPSY; COMORBIDITY; DRUG ADMINISTRATION; ESOPHAGUS; FEASIBILITY STUDY; FEMALE; GASTROSCOPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; IRRITABLE COLON; LOWER ESOPHAGUS SPHINCTER; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PATHOLOGY; PATIENT EDUCATION; PEPTIC ULCER; QUALITY OF LIFE; RECURRENT DISEASE; TREATMENT OUTCOME;

BIOPSY; COMORBIDITY; DRUG ADMINISTRATION SCHEDULE; ESOPHAGOGASTRIC JUNCTION; ESOPHAGUS; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; GASTROESOPHAGEAL REFLUX; GASTROSCOPY; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IRAN; IRRITABLE BOWEL SYNDROME; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OMEPRAZOLE; PATIENT EDUCATION AS TOPIC; PEPTIC ULCER; PROSPECTIVE STUDIES; QUALITY OF LIFE; RECURRENCE; TREATMENT OUTCOME;

EID: 38449095709     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-7-42     Document Type: Article

References (26)

1. Locke GR 3rd Talley NJ Fett SL Zinsmeister AR Melton U 3rd Prevalence and clinical spectrum of gastroesophageal reflux: A population based study in Olmsted County, Minnesota Gastroenterology 1997, 112(5):1448-56. 10.1016/S0016-5085(97)70025-8 9136821
2. El-Serag HB Sonnenberg A Opposing time trends of peptic ulcer and reflux disease Gut 1998, 43(3):327-33. 1727258 9863476
3. Dent J El-Serag HB Wallander M-A Johansson S Epidemiology of gastroesophageal reflux disease: A systematic review Gut 2005, 54:710-717. 10.1136/gut.2004.051821 15831922
4. Nasseri-Moghaddam S Malekzadeh M Sotoudeh M Tavangar M Azimi K Sohrabpour AA Mostadjabi P Fathi H Minapoor M Lower esophagus in dyspeptic Iranian patients: A prospective study J Gastroenterol Hepatol 2003, 18(3):5-21. 10.1046/j.1440-1746.2003.02969.x
5. Nouraie M Razjouyan H Assady M Malekzadeh R Nasseri-Moghaddam S Epidemiology of Gastroesophageal Reflux Symptoms in Tehran, Iran; a population-based Telephone Survey Arch Iran Med 2007, 10(3):289-294. 17604463
6. Wicklund IK Glise H Quality of life in different gastrointestinal conditions Eur J Surg Suppl 1998, 582:56-61. 10029366
7. Revicki DA Wood M Maton PN Sorensen S The impact of gastroesopgaheal reflux disease, on health-related quality of life Am J Med 1998, 104(3):252-8. 10.1016/S0002-9343(97)00354-9 9552088
8. Armstrong D Endoscopic evaluation of gastro-esophageal reflux disease Yale J Biol Med 1999, 72(2-3):93-100. 10780570
9. Saidi F Malekzadeh R Sotoudeh M Derakhshan MH Farahvash MJ Yazdanbod A Merat S Mikaeli J R Sotoudehmanesh Nasseri-Moghadam S Majidpour A Arshi S Abedi-Ardakani B Yoonessi A Sadr F Sepehr A Fleischer D Fahimi S Endoscopic esophageal cancer survey in the western part of the Caspian Littoral Diseases of the Esophagus 2002, 15:214-218. 10.1046/ j.1442-2050.2002.00250.x 12444993
10. Spechler SJ Epidemiology and natural history of gastro-oesophageal reflux disease Digestion 1992, 51(Suppl 1):24-9. 1397743
11. Locke GR Talley NJ Fett SL Zinsmeister AR Melton LJ Risk factors associated with symptoms of gastroesophageal reflux Am J Med 1999, 106:642-49. 10.1016/S0002-9343(99)00121-7 10378622
12. Galmiche JP Bruley des Varannes S Symptoms and disease severity in gastro-oesophageal reflux disease Scand J Gastroenterol Suppl 1994, 201:62-8. Review 10.3109/00365529409105366 8047826
13. Carlsson R Dent J Watts R Riley S Sheikh R Hatlebakk J Haug K de Groot G van Oudvorst A Dalvag A Junghard O Wiklund I Gastro-oesophageal reflux disease in primary care: An international study of different treatment strategies with omeprazole. International GORD Study Group Eur J Gastroenterol Hepatol 1998, 10(2):119-24. 10.1097/ 00042737-199802000-00004 9581986
14. Gerson LB Shetler K Triadafilopoulos G Prevalence of Barrett's esophagus in asymptomatic individuals Gastroenterology 2002, 123(2):461-7. 10.1053/ gast.2002.34748 12145799
15. Avidan B Sonnenberg A Schnell TG Sontag SJ Acid reflux is a poor predictor for severity of erosive reflux esophagitis Dig Dis Sci 2002, 47(11):2565-73. 10.1023/A:1020580630594 12452396
16. Lieberman DA Oehlke M Helfand M Risk factors for Barrett's esophagus in community-based practice. GORGEconsortium. Gastroenterology Outcomes Research Group in Endoscopy Am J Gastroenterol 1997, 92(8):1293-97. 9260792
17. Conio M Filiberti R Blanchi S Ferraris R Marchi S Ravelli P Lapertosa G Iaquinto G Sablich R Gusmaroli R Aste H Giacosa A Gruppo Operativo per lo Studio delle Precancerosi Esofagee (GOSPE) [Risk factors for Barrett's esophagus: A case-control study] Int J Cancer 2002, 97(2):225-29. 10.1002/ijc.1583 11774268
18. Cameron AJ Ott BJ Payne WS The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus N Engl J Med 1985, 313(14):857-859. 4033716
19. Eisen G The epidemiology of gastroesophageal reflux: What we know and what we need to know Am J Gastroenterol 2001 96(suppl):S16-18. 10.1016/ S0002-9270(01)02580-1
20. Isolauri J Luostarinen M Isolauri E Reinikainen P Viljakka M Keyrilainen O Natural course of gastroesophageal reflux disease: 17-22 year follow-up of 60 patients Am J Gastroenterol 1997, 92:37-41. 8995934
21. McDougall NI Johnston BT Collins JS McFarland RJ Love AH Three to 4.5 year prospective study of prognostic indicators in gastrooesophageal reflux disease Scand J Gastroenterol 1998, 33:1016-22. 10.1080/ 003655298750026688 9829353
22. Labenz J Jaspersen D Kulig M Leodolter A Lind T Meyer-Sabellek W Stolte M Vieth M Willich S Malfertheiner P Risk factors for erosive esophagitis: A multivariate analysis based on the ProGERD study initiative Am J Gastroenterol 2004, 99(9):1652-6. 10.1111/ j.1572-0241.2004.30390.x 15330897
23. Lundell LR Dent J Bennett JR Blum AL Armstrong D Galmiche JP Johnson F Hongo M Richter JE Spechler SJ Tytgat GN Wallin L Endoscopic assessment of oesophagitis: Clinical and functional correlates and further validation of the Los Angeles classification Gut 1999, 45(2):172-80. 1727604 10403727
24. Dixon MF Genta RM Yardley JH Correa P Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994 Am J Surg Pathol 1996, 20(10):1161-81. Review 10.1097/00000478-199610000-00001 8827022
25. Tofangchiha S Razjouyan H Ghotbi MH Nouraie M Alimohammadi M Mamarabadi M Nasrollahzadeh D Didar L Mofid A Malekzadeh R Nasseri-Moghaddam S Validation of the Quality of Life In Reflux and Dyspepsia (QOLRAD) Questionnaire in Patients with Iranian patients with GERD [abstract] Govaresh 2006, 11:s28.
26. Montazeri A Goshtasebi A Vahdaninia M Gandek B The Short Form Health Survey (SF-36): Translation and validation study of the Iranian version Qual Life Res 2005, 14:875-882. 10.1007/s11136-004-1014-5 16022079